Who owns Gentiva Hospice

Gentiva Hospice - Profile

Gentiva Health Services is a United States end of life and home based care provider headquartered in Atlanta, Georgia. It delivers hospice, palliative, community and personal care to patients in their own homes, nursing facilities and inpatient units, operating through regional brands including Gentiva Hospice, Heartland Hospice, Heartland Home Health, Hospice Plus, New Century Hospice, SouthernCare, Regency SouthernCare and Empatia Palliative Care. The company was formed on 11 August 2022 when the hospice and personal care divisions of Kindred at Home were carved out and recapitalised with the private equity firm Clayton, Dubilier & Rice taking majority control. It has since grown by acquisition, notably buying ProMedica's home health and hospice business in November 2023, and runs more than 600 locations across 38 states with over 35,000 staff.

The disclosed stakes

One row per position. Where a holder reports the same company in two share classes, both rows are shown rather than summed, because the class is part of a position's identity.

Where each figure comes from

A private stake has no ownership form behind it, so the source is always the holder's own filing or disclosure. Anything modelled says so, with the arithmetic.

• Humana Inc., as of 31 Dec 2025. Humana's FY2025 10-K, Note 4 'EQUITY METHOD INVESTMENTS', states it sold a 60% interest in Gentiva Hospice on 11 Aug 2022 and accounts for its remaining ~35% ownership using the equity method; it discloses Gentiva Hospice's own summarized balance sheet: total shareholders' equity $1,335 million at 31 Dec 2025 ($1,468 million at 31 Dec 2024). Humana's own consolidated balance sheet line 'Equity method investments' was $638 million at 31 Dec 2025 and $627 million at 30 Jun 2026 (10-Q), but Note 4 immediately follows the Gentiva disclosure with a separate paragraph, 'Other equity method investments: We have several other individually immaterial equity method investments included within equity method investments in our consolidated balance sheets', so that combined balance-sheet total is NOT Gentiva Hospice's carrying value alone and is not assigned to it per the brief's rule against sizing one investee from a combined balance. Instead, value_usd here is MODELLED as 35% x Gentiva Hospice's own reported shareholders' equity of $1,335 million at 31 Dec 2025 (the balance sheet Humana itself discloses for the investee) = approximately $467.25 million. This is a derived estimate of the equity interest's book value, not Humana's actual GAAP carrying amount, which is not separately disclosed anywhere in the reviewed filings. pct_of_target is written as 35, matching the filing's own words ('approximately 35%'), not as a fraction. sourcesource 2